We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
amsbio Announce Further Additions to its Enzyme Assays Portfolio
Product News

amsbio Announce Further Additions to its Enzyme Assays Portfolio

amsbio Announce Further Additions to its Enzyme Assays Portfolio
Product News

amsbio Announce Further Additions to its Enzyme Assays Portfolio


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "amsbio Announce Further Additions to its Enzyme Assays Portfolio"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

amsbio has announced further additions to its enzyme assays portfolio. New Direct Activity Assay kits for methyltransferases - PRMT1, 3, 5 and Set 7/9 have been developed to enable the measurement of enzyme activity using purified enzymes or enzyme containing extracts.

Each Direct Activity Assay Kit is supplied in a convenient 96-well plate pre-coated with peptide substrates, an antibody against the specific methylated target, a secondary Europium-labeled antibody, S-adenosylmethionine, methyltransferase assay buffer, and purified enzyme for 100 enzyme reactions.

The key to the new Direct Activity Assay Kits are highly specific antibodies that recognize methylated residues of the different substrates and only a few simple steps are required for detection of methyltransferase activity.

Firstly, enzyme and co-substrate are incubated in the substrate coated microtitre wells. Next, primary antibody is bound to the methylated substrate. Finally, the plates are treated with a Europium-labeled secondary antibody followed by addition of the enhancer to produce fluorescence at 620 nm. Fluorescence can then be measured using a fluorescence reader equipped for the measurement of time-resolved fluorescence.
Advertisement